Behçet's disease complicated with thrombosis: a report of 93 Chinese cases
Xiuhua Wu1, Guohua Li, Xinxiang Huang
1From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China (XW, LW, YZ, WZ); Department of Nephrology, Inner Mongolia Hospital of Traditional Chinese Medicine, Hohhot, 010020, China (GL); Department of Rheumatology and Hematology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China, 530021 (XH); and MOE Key Laboratory of Protein Science, School of Life Sciences, Tsinghua University, Beijing, 100084, China (WL).
Insights
Behçet
Area of Science:
- Rheumatology
- Vascular Medicine
- Clinical Immunology
Background:
- Behçet's disease (BD) is a multisystemic vasculitis with a propensity for thrombotic events.
- Thrombosis is a significant complication of BD, impacting patient morbidity and mortality.
Purpose of the Study:
- To investigate the clinical characteristics of thrombosis in patients with Behçet's disease.
- To identify risk factors and patterns of thrombotic complications in BD.
Main Methods:
- Retrospective review of medical records of 766 BD patients from 1993 to 2013.
- Analysis of demographic, clinical, and laboratory data for patients who developed thrombosis.
Main Results:
- 93 out of 766 BD patients (12.1%) developed thrombosis, predominantly venous (94.6%) and multiple (94.6%).
- Extremity vein thrombosis was most common (86.0%), followed by vena cava (30.1%) and pulmonary thromboembolism (15.1%).
- Male predominance for extremity vein thrombosis and female predominance for cerebral venous thrombosis (CVT) were observed. Active disease correlated with thrombotic events.
Conclusions:
- Thrombosis in Behçet's disease is characterized by male predominance, multiplicity, and a predilection for venous sites.
- Active disease necessitates aggressive immunosuppressive therapy to manage and prevent thrombotic complications.
- Understanding these patterns aids in early diagnosis and tailored management strategies for BD patients at risk of thrombosis.
Abstract:
To investigate the clinical features of Behçet's disease (BD) complicated with thrombosis. Medical records of patients with BD at Peking Union Medical College Hospital from 1993 to 2013 were reviewed to identify thrombosis. Of the 766 patients with BD, 93 patients (16 female and 77 male) developed thrombosis. The most common thrombosis was extremity vein thrombosis (86.0%), including deep vein thrombosis (n=78) and superficial thrombophlebitis (n=4). The other thrombosis types associated with BD in descending frequency of order were: vena cava thrombosis (30.1%), pulmonary thromboembolism (15.1%), cerebral venous thrombosis (CVT) (12.9%), intracardiac thrombosis (8.6%), Budd-Chiari syndrome (7.5%), and renal vein thrombosis (4.3%), etc. Venous thrombosis is more frequent than arterial thrombosis, and most of patients (94.6%) experienced multiple thrombosis. A male predominance of extremity vein thrombosis and positive pathergy test, and a female predominance of CVT and genital ulcers were noted. All of these patients exhibited active disease during the emergence of thrombotic events. After treating with glucocorticosteroids, immunosuppressants, and/or anticoagulants, the thrombosis resolved in 89 patients. Three patients died from aneurysm rupture, myocardial infarction and Budd-Chiari syndrome, respectively. One patient with septic shock discontinued therapy during follow-up. Thrombosis in BD patients is male predominance, mainly multiple and venous thrombosis is more common. Active disease patients are prone to thrombosis, which suggest the key role of immunosuppressive therapy for the complication.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hypersensitivity Reactions: Immune-Complex Reactions
Portal Hypertension
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
